The ex vivo expansion capacity of normal human bone marrow cells is dependent on experimental conditions: Role of the cell concentration, serum and CD34+ cell selection in stroma-free cultures

被引:32
|
作者
Poloni, A
Giarratana, MC
Firat, H
Kobari, L
Gorin, NC
Douay, L
机构
[1] HOP TROUSSEAU,SERV HEMATOL BIOL,F-75012 PARIS,FRANCE
[2] CHU ST ANTOINE,CTR CLAUDE BERNARD,CTR THERAPIE CELLULAIRE,F-75571 PARIS,FRANCE
[3] HOP ST ANTOINE,INSERM,U417,F-75571 PARIS 12,FRANCE
来源
HEMATOLOGY AND CELL THERAPY | 1997年 / 39卷 / 02期
关键词
expansion; hematopoietic stem cells; LTC-IC; progenitors;
D O I
10.1007/s00282-997-0049-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study was conducted to establish defined culture conditions for ex vivo expansion of normal human bone marrow cells. We investigated the role of three experimental expansion parameters: the cell concentration in the initial culture medium, the role of animal serum, human plasma and serum-free substitute, and the expansion potential of mononucleated cells (MNC) versus CD34+ cells. Cells were cultured in suspension with stem cell factor (SCF), IL3, IL6 and Erythropoietin (Epo) for 10 days. 1) Reducing the cell concentration from 3 x 10(4) to 1.5 x 10(3)/ml increased total cell expansion almost 20 fold, progenitor expansion more than 3 fold, and the maintenance of long term culture-initiating cells (LTC-IC). 2) In medium containing a serum-free substitute, total and CD34+ cell expansion was 3 times greater than in medium containing 1-10% human AB plasma or 25% animal serum. 3) The expansion potential of selected CD34+ cells was significantly greater than that of the total MNC population. However, taking into account the cell loss due to CD34+ selection, the overall results for quantitative expansion in relation to the initial number of MNCS favor the use of non-selected MNCS. 4) SCF+IL3+IL6 was clearly the best combination of early cytokines for LTC-IC maintenance, with or without lineage-restricted cytokines, whereas the presence of IL1 beta in any combination augmented the decrease in LTC-IC. Addition of G-CSF to the medium resulted in 1 log increase in total cell expansion and a 2-fold increase in CFU-GM expansion. Addition of Epo always induced a dramatic proliferation of erythroid cells (up to 2000 fold) as well as of CFU-GM (up to 4 fold), without exhausting the LTC-IC pool. We concluded that the expansion of hemopoietic cells for clinical purposes needs establishment of controlled, reproducible and reliable culture conditions.
引用
收藏
页码:49 / 58
页数:10
相关论文
共 42 条
  • [1] Ex vivo expansion of bone marrow progenitor cells: Effect of CD34+ selection
    Redondo, M
    Rifon, J
    Inoges, S
    Panizo, C
    RodriguezCalvillo, M
    Cuesta, B
    Rocha, E
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 935 - 935
  • [2] COMPARISON OF SERUM-FREE, STROMA-FREE CULTURES WITH SERUM-CONTAINING, STROMA-CONTACT AND STROMA NONCONTACT CULTURES ON CD34+ CELL-GROWTH
    AONO, F
    MAMPE, BA
    MARTINSON, JA
    SIMPSON, SJ
    VACHULA, M
    FASEB JOURNAL, 1995, 9 (03): : A501 - A501
  • [3] CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells
    Kobari, L
    Giarratana, MC
    Pflumio, F
    Izac, B
    Coulombel, L
    Douay, L
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2001, 10 (02): : 273 - 281
  • [4] Ex vivo expansion and clonality of CD34+ selected cells from bone marrow and cord blood in a serum-free media
    Kim, SK
    Koh, SK
    Song, SU
    Shin, SH
    Choi, GS
    Kim, WC
    Lee, MH
    Seoh, JY
    Park, SK
    Fraser, JK
    MOLECULES AND CELLS, 2002, 14 (03) : 367 - 373
  • [5] Human neonatal blood:: stem cell content, kinetics of CD34+ cell decline and ex vivo expansion capacity
    Li, K
    Liu, J
    Fok, TF
    Yau, FW
    Wong, A
    Li, CK
    Yang, M
    So, KW
    Chik, KW
    Tsang, KS
    Shing, MMK
    Yuen, PMP
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) : 178 - 185
  • [6] Cytokine-mediated generation of myeloid progenitors in stroma-free cultures of mobilized CD34+ blood cells: No evidence for tumor cell expansion in multiple myeloma
    VanRiet, I
    Schots, R
    Jung, N
    DeWaele, M
    Servotte, S
    Lacor, P
    VanCamp, B
    Bakkus, M
    BLOOD, 1995, 86 (10) : 235 - 235
  • [7] EX-VIVO EXPANSION OF HUMAN BONE-MARROW AND CORD-BLOOD CD34+ PROGENITOR CELLS
    HEIMFELD, S
    FEI, R
    TSUI, J
    THOMPSON, P
    BERENSON, RJ
    BLOOD, 1993, 82 (10) : A17 - A17
  • [8] A comparative study of the cell cycle status and primitive cell adhesion molecule profile of human CD34+ cells cultured in stroma-free versus porcine microvascular endothelial cell cultures
    Chute, JP
    Saini, AA
    Kampen, RL
    Wells, MR
    Davis, TA
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (02) : 370 - 379
  • [9] Loss of CD34+/CD38- cells during ex vivo expansion of purified CD34+ stem cells using adenoviral-based gene transfer of stem cell factor to bone marrow stromal cells.
    Kouroukis, C
    Soamboonsrup, P
    Schroeder, JA
    Sime, PJ
    Gauldie, J
    Foley, R
    BLOOD, 1998, 92 (10) : 151A - 151A
  • [10] EX-VIVO EXPANSION OF NORMAL HUMAN BONE-MARROW CD34+DR(LOW) CELLS IN LIQUID CULTURE
    HERMAN, P
    FERRANT, A
    MICHAUX, JL
    DEBRUYERE, M
    STRAETMANS, N
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 908 - 908